JP1676786S - - Google Patents

Info

Publication number
JP1676786S
JP1676786S JPD2020-12513F JP2020012513F JP1676786S JP 1676786 S JP1676786 S JP 1676786S JP 2020012513 F JP2020012513 F JP 2020012513F JP 1676786 S JP1676786 S JP 1676786S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-12513F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-12513F priority Critical patent/JP1676786S/ja
Priority to US29/755,406 priority patent/USD950825S1/en
Application granted granted Critical
Publication of JP1676786S publication Critical patent/JP1676786S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-12513F 2020-06-23 2020-06-23 Active JP1676786S (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2020-12513F JP1676786S (enExample) 2020-06-23 2020-06-23
US29/755,406 USD950825S1 (en) 2020-06-23 2020-10-20 Reflector for downlight

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-12513F JP1676786S (enExample) 2020-06-23 2020-06-23

Publications (1)

Publication Number Publication Date
JP1676786S true JP1676786S (enExample) 2021-01-18

Family

ID=74164852

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-12513F Active JP1676786S (enExample) 2020-06-23 2020-06-23

Country Status (2)

Country Link
US (1) USD950825S1 (enExample)
JP (1) JP1676786S (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD990744S1 (en) * 2016-04-28 2023-06-27 Juna Construction, Inc. Recessed light fixture

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD370550S (en) * 1994-09-26 1996-06-04 Michel Lecluze Trim ring for recessed lighting fixture
USD381454S (en) * 1995-12-04 1997-07-22 Michel Lecluze Trim for recessed lighting fixture
USD381111S (en) * 1996-05-06 1997-07-15 Michel Lecluze Trim for embedded light fixture
USD380852S (en) * 1996-05-10 1997-07-08 Michel Lecluze Trim for embedded light fixture
USD399590S (en) * 1997-06-27 1998-10-13 Michel Lecluze Trim for recessed light fixture
USD397490S (en) * 1997-06-30 1998-08-25 Michel Lecluze Trim for recessed light fixture
USD488252S1 (en) * 2003-05-12 2004-04-06 Bazz Inc. Lamp fitting
USD599951S1 (en) * 2007-05-03 2009-09-08 Cree Led Lighting Solutions, Inc. Lighting device
USD671668S1 (en) * 2010-12-03 2012-11-27 Cree, Inc. Lighting fixture
USD653799S1 (en) * 2011-02-18 2012-02-07 ExpoImaging, Inc. Light grid bezel
EP2997303B1 (en) * 2013-05-14 2017-06-28 Philips Lighting Holding B.V. Housing for securing a recessed fixture.
USD859732S1 (en) * 2017-09-12 2019-09-10 Kinace Innovations Limited Light guide for LED lamp
JP1624793S (enExample) * 2018-07-24 2019-02-18

Also Published As

Publication number Publication date
USD950825S1 (en) 2022-05-03

Similar Documents

Publication Publication Date Title
BR112021017747A2 (enExample)
BR102021007058A2 (enExample)
JP1676786S (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134141A1 (es) Conjugados anticuerpo-fármaco anti-napi2b y métodos de uso
AR134150A1 (es) ÁCIDO NUCLEICO INHIBIDOR DIRIGIDO A LA EXPRESIÓN DE a SINUCLEÍNA